Cargando…
Correction: Kędzierska, H., et al. Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer. Int. J. Mol. Sci. 2016, 17, 1598
Autores principales: | Kędzierska, Hanna, Popławski, Piotr, Hoser, Grażyna, Rybicka, Beata, Rodzik, Katarzyna, Sokół, Elżbieta, Bogusławska, Joanna, Tański, Zbigniew, Fogtman, Anna, Koblowska, Marta, Piekiełko-Witkowska, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177211/ https://www.ncbi.nlm.nih.gov/pubmed/32235585 http://dx.doi.org/10.3390/ijms21072380 |
Ejemplares similares
-
Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer
por: Kędzierska, Hanna, et al.
Publicado: (2016) -
MicroRNA-Mediated Metabolic Reprograming in Renal Cancer
por: Bogusławska, Joanna, et al.
Publicado: (2019) -
Epigenetic Regulation of Thyroid Hormone Receptor Beta in Renal Cancer
por: Wojcicka, Anna, et al.
Publicado: (2014) -
Coordinated reprogramming of renal cancer transcriptome, metabolome and secretome associates with immune tumor infiltration
por: Poplawski, Piotr, et al.
Publicado: (2023) -
Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors
por: Piekielko-Witkowska, Agnieszka, et al.
Publicado: (2010)